En DE FR ES PL
Silimar - instructions for use, analogs, reviews and release forms (100 mg tablets) medications based on the extract of thistle fruits for the treatment of hepatitis, cirrhosis, alcoholic liver disease in adults, children and pregnancy. Composition

Silimar - instructions for use, analogs, reviews and release forms (100 mg tablets) medications based on the extract of thistle fruits for the treatment of hepatitis, cirrhosis, alcoholic liver disease in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Sylimar. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Silimar in their practice. A big request is to actively add your feedback about the drug on the basis of the extract of the Milk thistle fruit: the medicine helped or did not help to get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Sylimard with available structural analogues.Use for the treatment of hepatitis, cirrhosis, alcoholic liver disease in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

 

Sylimar - Hepatoprotective preparation of plant origin. Has a hepatoprotective and antitoxic effect. The therapeutic effect is due to the influence on the metabolism of hepatocytes. Activates the synthesis of proteins and enzymes in hepatocytes, has a stabilizing effect on the membrane of hepatocytes, inhibits the penetration of toxins into the liver cells, inhibits dystrophic and potentiates the regenerative processes in the liver.

 

Composition

 

Extract of fruits of milk thistle spotted + auxiliary substances.

 

Indications

  • toxic liver damage;
  • chronic hepatitis;
  • cirrhosis of the liver (as part of complex therapy);
  • condition after hepatitis;
  • with the goal of preventing chronic intoxications (including occupational), long-term use of drugs and alcohol.

 

Forms of release

 

Tablets of 100 mg.

 

Instructions for use and dosing regimen

 

Assign adults to adults 1-2 tablets 3 times a day. The course of treatment is 25-30 days. If necessary, the course is repeated after 1-3 months.

 

The drug is taken 30 minutes before meals.

 

Side effect

  • allergic reactions;
  • a lenient action.

 

Contraindications

  • hypersensitivity to the components of the drug.

 

Application in pregnancy and lactation

 

It is not recommended to prescribe the drug Silimar during pregnancy and lactation (breastfeeding).

 

Use in children

 

It is not recommended to prescribe the drug to children under the age of 12 years.

 

special instructions

 

The drug should be stored out of the reach of children, dry, protected from light. Shelf life - 3 years.

 

Drug Interactions

 

It is acceptable to use the drug in complex schemes of therapy for liver diseases.

 

Analogues of the drug Silimar

 

Structural analogs for the active substance:

  • Karsil;
  • Karsil Forte;
  • Legalon;
  • Silegon;
  • Silibinin;
  • Silymarin.

 

Analogues for the pharmacological group (hepatoprotectors):

  • Alpha lipoic acid;
  • Antraliv;
  • Berlition;
  • Bicyclic;
  • Brentzialle forte;
  • Vitanorm;
  • Gepa Merz;
  • Hepatosan;
  • Heptor;
  • Heptral;
  • Heptrog;
  • Glutargin;
  • Grinterol;
  • Covechol;
  • Kedrostat;
  • Larnamine;
  • Liventziale;
  • Livedoksa;
  • Livolife Forte;
  • Lipoic acid;
  • Maxar;
  • Methionine;
  • Metrop;
  • Moliksan;
  • Octolipen;
  • Ornilatex;
  • Ornitsetil;
  • Polythion;
  • Resalute Pro;
  • Sirepard;
  • Thioctic acid;
  • Thiolipone;
  • Tiotriazolin;
  • Urdoks;
  • Urso 100;
  • Ursodeoxycholic acid;
  • Ursodez;
  • Ursodex;
  • Ursuliv;
  • Ursolit;
  • Ursomik;
  • Ursoprim;
  • Ursor;
  • Ursosan;
  • Ursofalk;
  • Phosphontsiale;
  • Hepabos;
  • Holudexan;
  • Exxhol;
  • Erbisol;
  • Essentiale N;
  • Essentiale forte N;
  • Essential phospholipids;
  • Essley forte;
  • The Essler.

Similar medicines:

Other medicines:

Reviews (0):

Rules for publishing reviews and visitor questions